Regulatory briefing on the CBD sector

CBD vaping will not be allowed under Massachusetts ban exemption

Written by Freddie Dawson || 13th November 2019 || Regulatory briefing |

Massachusetts

North America

United States

Regulation and Legislation

Regulatory briefing

CBD vaping will not be permitted under an exemption from cannabis regulators to the vaping ban brought in by the Republican governor of Massachusetts, Charlie Baker ...

Portugal steps up enforcement over edibles with seizure in Porto

Written by Marija Obradovic || 13th November 2019 || Regulatory briefing |

Europe

Portugal

Regulation and Legislation

Regulatory briefing

Authorities in Porto recently seized over 500 edible products, stepping up enforcement efforts ...

NYPD acts on FedEx tip-off that was shrugged off by police in Vermont

Written by CBD-Intel || 12th November 2019 || Regulatory briefing |

California

Colorado

New York

North America

Tennessee

United States

Vermont

Regulation and Legislation

Regulatory briefing

Police in Vermont were satisfied with the legality of a shipment of hemp after being tipped off by delivery company FedEx – but the New York Police Department took a different view ...

New UK trade association places its focus on EU novel food regulations

Written by CBD-Intel || 7th November 2019 || Regulatory briefing |

Europe

United Kingdom

Companies

Policy and Politics

Regulatory briefing

The Centre for Medical Cannabis is launching a new Association for the Cannabinoid Industry (ACI), claiming to be the first CBD trade organisation in the UK to ensure compliance with EU novel food regulations ...

Trump nominee Hahn unlikely to change much as FDA commissioner

Written by CBD-Intel || 6th November 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Little is expected to change at the US FDA in terms of CBD or cannabis policy if president Donald Trump’s nominee Stephen Hahn is approved as commissioner, according to sources contacted by CBD-Intel ...

CBD regulation will not be forgotten by new Polish parliament, says ex-MP

Written by CBD-Intel || 5th November 2019 || Regulatory briefing |

Europe

Poland

Regulation and Legislation

Regulatory briefing

CBD issues will be addressed in Poland's next parliamentary session, according to former MP Piotr Liroy-Marzec ...

Hemp extraction proposal falls short of solving Italian regulation chaos

Written by CBD-Intel || 4th November 2019 || Regulatory briefing |

Europe

Italy

Companies

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

A proposal to regulate the sale of hemp biomass in Italy has been put before the Agriculture Committee of the Chamber of Deputies, but members of the industry fear it does not go far enough in allowing use...

Ukraine’s new government drops plan to legalise medical cannabis

Written by CBD-Intel || 31st October 2019 || Regulatory briefing |

Europe

Ukraine

Policy and Politics

Regulation and Legislation

Regulatory briefing

The legalisation of medical cannabis in Ukraine, which was expected this year, is now likely to be indefinitely suspended following a decision not to include cannabis in the list of substances permitted in the country ...

Agriculture department set to issue rules for US national hemp program

Written by CBD-Intel || 30th October 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US Department of Agriculture (USDA) has announced that it is preparing to release the interim final rules governing a national hemp product program ...

Slovakia’s parliament dashes hopes that CBD was to be legalised

Written by Lenka Hajnovicova || 28th October 2019 || Regulatory briefing |

Europe

Slovakia

Regulation and Legislation

Regulatory briefing

CBD remains banned in Slovakia after the country’s parliament, the National Council, defied widespread expectation that the substance would be legalised in line with the rest of Europe ...

US Northeast cannabis and vaping summit aims at joint regulation

Written by CBD-Intel || 28th October 2019 || Regulatory briefing |

Connecticut

Massachusetts

New Jersey

New York

North America

Pennsylvania

Rhode Island

United States

Regulation and Legislation

Regulatory briefing

Governors and lawmakers from six US states have met at a regional cannabis and vaping summit in an attempt to establish more collective standardised regulations and legislative approaches ...

Teething troubles as firms are warned over prohibited medical claims

Written by Freddie Dawson || 24th October 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

Federal enforcement against CBD medical claims in the US is going strong, with the Federal Trade Commission (FTC) recently sending a warning letter to a new company about what it said were prohibited medical claims ...

Colorado works on rules to ban additives linked to vaping scare

Written by CBD-Intel || 24th October 2019 || Regulatory briefing |

Colorado

North America

United States

Regulation and Legislation

Regulatory briefing

Regulators in the US state of Colorado are preparing to finalise rules that ban certain additives in cannabinoid vaping liquids – but a question remains over who is to oversee and enforce those rules ...

Few complaints and little enforcement – but EU food rules still apply in UK

Written by CBD-Intel || 22nd October 2019 || Regulatory briefing |

Europe

United Kingdom

Regulation and Legislation

Regulatory briefing

UK Trading Standards teams report very few complaints about food and drink containing CBD, despite the Food Standards Agency (FSA) saying it would follow EU rules, which say CBD should not be used as an ingredient in foodstuffs...

Caution required when advertising food containing CBD, rules UK ASA

Written by Freddie Dawson || 22nd October 2019 || Regulatory briefing |

Europe

United Kingdom

Companies

Policy and Politics

Regulatory briefing

Companies can advertise food and drinks as containing CBD, however, they should be careful about implying any link to illicit drugs like cannabis, according to the UK Advertising Standards Authority (ASA) ...

CBD-Intel regulatory news in brief, 15th-21st October

Written by CBD-Intel || 21st October 2019 || Regulatory briefing |

Africa

California

Canada

Europe

Germany

Idaho

Illinois

Lithuania

Mexico

North America

Slovakia

Texas

United States

Virginia

Wisconsin

Zimbabwe

Regulation and Legislation

Regulatory briefing

Zimbabwe sees its first legal hemp crop planted after being awarded its first licence. This, and other news from the US, Canada, Mexico, Brazil, Germany, Lithuania and Slovakia in our regular regulatory round-up ...

Swedish court rules CBD does not make a product pharmaceutical

Written by CBD-Intel || 14th October 2019 || Regulatory briefing |

Europe

Sweden

Regulation and Legislation

Regulatory briefing

A Swedish court has ruled that a product containing CBD for oral consumption cannot automatically be classified as a pharmaceutical, but that the legal status of each product must be assessed individually ...

CBD across the US still caught up in a tangle of inconsistent enforcement

Written by CBD-Intel || 8th October 2019 || Regulatory briefing |

Iowa

North America

Texas

United States

Washington D.C.

Policy and Politics

Regulation and Legislation

Regulatory briefing

Despite various bodies making steps towards legalisation, the existing legal environment for CBD across the US remains a patchwork of contradictory policies ...

CBD-Intel regulatory news in brief, 26th-30th September

Written by CBD-Intel || 30th September 2019 || Alerts roundup , Regulatory briefing |

Connecticut

Europe

Kentucky

Massachusetts

New Jersey

New York

North America

Oregon

Poland

Rhode Island

United States

Washington

Public Health and Medicine

Regulation and Legislation

Alerts roundup

Regulatory briefing

Moves are under way in a number of US states to take executive action against various vapour products. Meanwhile, a Kentucky CBD firm is suing for $44m an Oregon company it says sold it “nearly worthless” hemp seeds...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 26th September 2019 || Alerts roundup , Regulatory briefing |

Australasia

Australia

Canada

Colombia

Europe

Finland

France

Illinois

Italy

Luxemburg

Massachusetts

North America

Paraguay

San Marino

South America

United States

Regulation and Legislation

Alerts roundup

Regulatory briefing

This bonus edition of CBD-Intel regulatory news in brief includes items from across North and South America as well as Europe and Australia ...

SAFE Banking Act safely through the US House, but obstacles remain

Written by CBD-Intel || 26th September 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

Passage of the Secure and Fair Enforcement (SAFE) Banking Act through the US House of Representatives is but one skirmish, with a potentially fiercer battle awaiting in the Senate and the White House ...

Malaysia looks to begin research into medical cannabis

Written by CBD-Intel || 24th September 2019 || Regulatory briefing |

Asia

Malaysia

Regulation and Legislation

Regulatory briefing

The Malaysian government is to allow the import, storage, distribution and sale of medical marijuana – as long as producers or importers can prove its safety and efficacy for medical use ...

CBD-based epilepsy drug Epidyolex gets the green light from Europe

Written by Barnaby Page || 23rd September 2019 || Regulatory briefing |

Europe

Regulation and Legislation

Regulatory briefing

Epidyolex, the CBD-based medicine used to treat rare forms of epilepsy, has been approved by the European Medicines Agency (EMA) ...

CBD-Intel regulatory news in brief, 17th-22nd September

Written by CBD-Intel || 23rd September 2019 || Alerts roundup , Regulatory briefing |

Asia

Austria

California

Colombia

Ecuador

Europe

Florida

France

Indiana

Italy

North America

South America

United Arab Emirates

United Kingdom

United States

Regulation and Legislation

Alerts roundup

Regulatory briefing

A court in Indiana has ruled the state ban on smokable hemp unconstitutional. This, and other news from the US, Austria, France, Italy, the UK, Colombia, Ecuador and the UAE in our regular regulatory round-up ...

US Senate committee allocates cash to speeding up CBD regulation

Written by CBD-Intel || 23rd September 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

US Senate majority leader Mitch McConnell is to attach funding to the agricultural appropriations bill to speed the FDA’s preliminary steps towards rulemaking for CBD products ...

Quebec plans to defy edibles and topicals legalisation in Canada

Written by CBD-Intel || 20th September 2019 || Regulatory briefing |

Canada

North America

Marketing and Retailing

Policy and Politics

Regulation and Legislation

Regulatory briefing

As Canada prepares for the legalisation of cannabis edibles and topical creams this autumn, one province wants to restrict them. Quebec has served notice that it plans to adopt its own set of regulations banning cannabis-laced edibles that...

CBD-Intel regulatory news in brief, 10th-16th September

Written by CBD-Intel || 16th September 2019 || Alerts roundup , Regulatory briefing |

Asia

Austria

Europe

Germany

Hawaii

India

Israel

Italy

Louisiana

Myanmar

North America

Switzerland

United States

Policy and Politics

Regulation and Legislation

Alerts roundup

Regulatory briefing

Regulatory developments from the US, EU, Germany, Italy, India, Israel and Myanmar – and news of an “illegal” incursion into Austria by undercover Swiss border guards ...

Raided German CBD sellers left in limbo with no legal charges yet

Written by CBD-Intel || 10th September 2019 || Regulatory briefing |

Europe

Germany

Regulation and Legislation

Regulatory briefing

Five months after police in Bavaria and Baden-Württemberg raided CBD shops and confiscated goods worth hundreds of thousands of euros, no charges have yet been filed ...

CBD regulatory news in brief, 3rd – 9th September

Written by CBD-Intel || 9th September 2019 || Alerts roundup , Regulatory briefing |

Asia

Australasia

Australia

Belgium

Europe

Germany

Ireland

Myanmar

Sweden

Thailand

Companies

Market Research

Marketing and Retailing

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Alerts roundup

Regulatory briefing

South Dakota governor Kristi Noem has explained why she continues to oppose hemp legalisation in the state; Flanders in Belgium is seeing enforcement action against CBD shops because of CBD oils and teas; Australian state Victoria may yet...

California hemp bill delays legalisation of foods, beverages and cosmetics with hemp-based CBD

Written by Freddie Dawson || 9th September 2019 || Regulatory briefing |

California

North America

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The launch of many CBD-containing foods, beverages and cosmetics in California has been delayed further as a bill legalising their sale is now not expected to pass before the end of the legislative session, which ends on on...

A step forward as US DEA expands cannabinoid scientific research

Written by Freddie Dawson || 5th September 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US Drug Enforcement Agency has decided to expand cannabinoid scientific research and no longer requires registration for the growth or research of hemp ...

Russia poised to open up to CBD after Duma agrees to lift cultivation ban

Written by CBD-Intel || 5th September 2019 || Regulatory briefing |

Russia

World

Regulation and Legislation

Regulatory briefing

Despite continuing uncertainty, the Russian CBD market is on the verge of big changes, following the approval of a draft bill by the national parliament ...

CBD-Intel regulatory news in brief, 27th August-2nd September

Written by CBD-Intel || 2nd September 2019 || Alerts roundup , Regulatory briefing |

Africa

Canada

Czech Republic

Europe

Ireland

Mexico

North America

Portugal

South Africa

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Alerts roundup

Regulatory briefing

Americans for Safe Access has issued the Patient’s Guide to CBD, Ireland sees increase in hemping-growing licence applications, and over 6000 plants have been seized in Portugal ...

CBD drug Epidyolex looks unlikely to get a NICE answer in the UK

Written by CBD-Intel || 29th August 2019 || Regulatory briefing |

Europe

United Kingdom

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The panel largely responsible for recommending which drugs the UK’s National Health Service (NHS) should provide may discourage use of the CBD-based drug Epidyolex ...

CBD-Intel regulatory news in brief, 19th-23rd August 2019

Written by CBD-Intel || 26th August 2019 || Alerts roundup , Regulatory briefing |

Asia

Austria

Croatia

Europe

Germany

Israel

Italy

North America

North Carolina

Slovakia

South Dakota

United States

Washington

Policy and Politics

Regulation and Legislation

Alerts roundup

Regulatory briefing

Austrian and German police policy, local THC decision in Italy, Slovakian de-scheduling, Croatian proposals, US federal and state rulings and Israeli priorities come under the regulatory spotlight ...

In the zone – Colombia’s promised new rules lead to optimism over exports

Written by CBD-Intel || 23rd August 2019 || Regulatory briefing |

Colombia

South America

Regulation and Legislation

Regulatory briefing

A new government decree in Colombia is expected to boost the hemp/cannabis export market by as early as the end of 2019, leading to optimism about the industry in the country ...

Italians sell CBD flowers as ‘animal feed’ to avoid confused enforcement

Written by CBD-Intel || 21st August 2019 || Regulatory briefing |

Europe

Italy

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

Some Italian companies have begun to register CBD hemp flower products as animal feed in an attempt to avoid regulatory confusion and uneven enforcement in the country ...

CannTrust’s future cast in doubt after renewed troubles with Health Canada

Written by CBD-Intel || 20th August 2019 || Regulatory briefing |

Canada

North America

Companies

Regulation and Legislation

Regulatory briefing

The future of one of Canada's largest cannabis companies is hanging in the balance after a whistleblower and an unannounced inspection by Health Canada triggered a series of problems for CannTrust ...

Mexico holds open talks in move towards legalisation of cannabis

Written by CBD-Intel || 19th August 2019 || Regulatory briefing |

Mexico

North America

Policy and Politics

Regulation and Legislation

Regulatory briefing

The precise role Mexico’s government should play in a future cannabis industry was among the major issues discussed at a recent three-day event hosted by the country’s Senate ...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 19th August 2019 || Alerts roundup , Regulatory briefing |

Asia

California

Europe

Germany

Italy

New Jersey

North America

South Dakota

Spain

Thailand

United Kingdom

United States

Policy and Politics

Regulation and Legislation

Alerts roundup

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey ...

First Jersey hemp licence issued – ‘a significant opportunity’ for island

Written by Freddie Dawson || 14th August 2019 || Regulatory briefing |

Europe

United Kingdom

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

Hemp can now be grown on the Channel Island of Jersey following the issuance of the first licence to harvest, process and store hemp flower in preparation for CBD...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 12th August 2019 || Alerts roundup , Regulatory briefing |

Alerts roundup

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Germany, Switzerland, Belgium, the UK, and the...

CBD-Intel bonus midweek regulatory alerts, 8th August 2019

Written by CBD-Intel || 8th August 2019 || Alerts roundup , Regulatory briefing |

Africa

Canada

Colombia

Europe

Mexico

North America

South America

United States

Zimbabwe

Companies

Marketing and Retailing

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Alerts roundup

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and...

CBD-Intel regulatory news in brief

Written by CBD-Intel || 5th August 2019 || Alerts roundup , Regulatory briefing |

Africa

Arizona

Canada

Europe

Germany

Italy

Luxemburg

Netherlands

North America

North Carolina

Ohio

South Africa

South Carolina

Spain

United States

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Alerts roundup

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa ...

MHRA enforces CBD rules with British store

Written by CBD-Intel || 1st August 2019 || Regulatory briefing |

England

Europe

United Kingdom

Companies

Marketing and Retailing

Regulation and Legislation

Regulatory briefing

A British shop specialising in hemp-related products says it has been told to remove some information from its website by the organisation responsible for regulating medicinal health...

Epidyolex takes huge step toward EU licensing

Written by CBD-Intel || 31st July 2019 || Regulatory briefing |

Europe

Companies

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European...

US urgently needs hemp regulations, Senate is told

Written by CBD-Intel || 30th July 2019 || Regulatory briefing |

North America

United States

Regulatory briefing

Rising demand for hemp products could soon make it an important cash crop for America but both industry and regulators must change to meet evolving demands and...

CannTrust leaders axed, confusion in Italy: regulatory news in brief

Written by CBD-Intel || 29th July 2019 || Alerts roundup , Regulatory briefing |

Canada

Europe

Italy

New York

North America

North Carolina

Portugal

Texas

United States

Washington

Regulation and Legislation

Alerts roundup

Regulatory briefing

CBD-Intel’s regular round-up of regulatory news features items from Canada, New York, Texas, Nevada, Washington State, Italy and Portugal ...

No Euphoria here – Ireland recalls Dutch oil from sale over THC content

Written by CBD-Intel || 26th July 2019 || Regulatory briefing |

Europe

Ireland

Regulation and Legislation

Regulatory briefing

A batch of CBD oil has been removed from sale by authorities in the Republic of Ireland after it was found to contain THC ...

Curaleaf in hot water with FDA over ‘improper health claims’

Written by Daniel Mollenkamp || 25th July 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety ...

Written by Freddie Dawson || 13th November 2019 || Regulatory briefing |

Written by Marija Obradovic || 13th November 2019 || Regulatory briefing |

Written by CBD-Intel || 12th November 2019 || Regulatory briefing |

Written by CBD-Intel || 7th November 2019 || Regulatory briefing |

Written by CBD-Intel || 6th November 2019 || Regulatory briefing |

Written by CBD-Intel || 5th November 2019 || Regulatory briefing |

Written by CBD-Intel || 4th November 2019 || Regulatory briefing |

Written by CBD-Intel || 31st October 2019 || Regulatory briefing |

Written by CBD-Intel || 30th October 2019 || Regulatory briefing |

Written by Lenka Hajnovicova || 28th October 2019 || Regulatory briefing |

Written by CBD-Intel || 28th October 2019 || Regulatory briefing |

Written by Freddie Dawson || 24th October 2019 || Regulatory briefing |

Written by CBD-Intel || 24th October 2019 || Regulatory briefing |

Written by CBD-Intel || 22nd October 2019 || Regulatory briefing |

Written by Freddie Dawson || 22nd October 2019 || Regulatory briefing |

Written by CBD-Intel || 21st October 2019 || Regulatory briefing |

Written by CBD-Intel || 14th October 2019 || Regulatory briefing |

Written by CBD-Intel || 8th October 2019 || Regulatory briefing |

Written by CBD-Intel || 30th September 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 26th September 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 26th September 2019 || Regulatory briefing |

Written by CBD-Intel || 24th September 2019 || Regulatory briefing |

Written by Barnaby Page || 23rd September 2019 || Regulatory briefing |

Written by CBD-Intel || 23rd September 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 23rd September 2019 || Regulatory briefing |

Written by CBD-Intel || 20th September 2019 || Regulatory briefing |

Written by CBD-Intel || 16th September 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 10th September 2019 || Regulatory briefing |

Written by CBD-Intel || 9th September 2019 || Alerts roundup , Regulatory briefing |

Written by Freddie Dawson || 9th September 2019 || Regulatory briefing |

Written by Freddie Dawson || 5th September 2019 || Regulatory briefing |

Written by CBD-Intel || 5th September 2019 || Regulatory briefing |

Written by CBD-Intel || 2nd September 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 29th August 2019 || Regulatory briefing |

Written by CBD-Intel || 26th August 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 23rd August 2019 || Regulatory briefing |

Written by CBD-Intel || 21st August 2019 || Regulatory briefing |

Written by CBD-Intel || 20th August 2019 || Regulatory briefing |

Written by CBD-Intel || 19th August 2019 || Regulatory briefing |

Written by CBD-Intel || 19th August 2019 || Alerts roundup , Regulatory briefing |

Written by Freddie Dawson || 14th August 2019 || Regulatory briefing |

Written by CBD-Intel || 12th August 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 8th August 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 5th August 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 1st August 2019 || Regulatory briefing |

Written by CBD-Intel || 31st July 2019 || Regulatory briefing |

Written by CBD-Intel || 30th July 2019 || Regulatory briefing |

Written by CBD-Intel || 29th July 2019 || Alerts roundup , Regulatory briefing |

Written by CBD-Intel || 26th July 2019 || Regulatory briefing |

Written by Daniel Mollenkamp || 25th July 2019 || Regulatory briefing |

Sign up to our newsletter

Subscribe for the latest industry updates

Don't miss out